This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saunders, N. Articles by Dahler, A. Search for Related Content PubMed PubMed Citation Articles by Saunders, N. Articles by Dahler, A.

Histone Deacetylase Inhibitors as Potential Anti-Skin Cancer Agents¹

Epithelial Pathobiology Group, Centre for Immunology and Cancer Research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, 4102 Australia

The regulation of squamous differentiation is a tightly regulated process involving transcriptional repression and activation. Previous studies have established that squamous carcinoma cell lines inappropriately regulate the transcription of genes important to the control of squamous differentiation. Histone deactylase inhibitors such as trichostatin A (TSA) and butyrate disrupt normal chromatin structure and cause alterations in gene expression/regulation. For these reasons, we examined the effects of both butyrate and TSA on the growth and differentiation of human keratinocytes or squamous carcinoma cells in tissue culture. We found that treatment of keratinocytes or squamous carcinoma cells with butyrate induced a reversible growth arrest. TSA, on the other hand, induced an irreversible growth arrest in both keratinocytes and squamous carcinoma cells. The growth arrest of keratinocytes induced by TSA or butyrate was accompanied by a reduction in the mRNA levels for proliferation gene cdk1 and an induction of the mRNA for the differentiation-specific transglutaminase type I gene (TG1). In contrast, the squamous carcinoma cells had decreased cdk1 and TG1 mRNA in response to TSA or butyrate. Both of these agents produced transient increases in the acetylation of histone H4 in keratinocytes and squamous carcinoma cells. These data indicated that TSA may have potential as a topical treatment for epidermal malignancies.

This article has been cited by other articles:

				T. S. Cunneen, R. M. Conway, and M. C. Madigan In Vitro Effects of Histone Deacetylase Inhibitors and Mitomycin C on Tenon Capsule Fibroblasts and Conjunctival Melanoma Cells Arch Ophthalmol, April 1, 2009; 127(4): 414 - 420. [Abstract] [Full Text] [PDF]

				W. Gu, J. Ding, X. Wang, R. L. de Kluyver, N. A. Saunders, I. H. Frazer, and K.-N. Zhao Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation Nucleic Acids Res., July 9, 2007; (2007) gkm496v1. [Abstract] [Full Text] [PDF]

				J. Duan, J. Friedman, L. Nottingham, Z. Chen, G. Ara, and C. Van Waes Nuclear factor-{kappa}B p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101 Mol. Cancer Ther., January 1, 2007; 6(1): 37 - 50. [Abstract] [Full Text] [PDF]

				M. Honma, M. Stubbs, I. Collins, P. Workman, W. Aherne, and F. M. Watt Identification of Novel Keratinocyte Differentiation Modulating Compounds by High-Throughput Screening J Biomol Screen, December 1, 2006; 11(8): 977 - 984. [Abstract] [PDF]

				N. K. Mukhopadhyay, E. Weisberg, D. Gilchrist, R. Bueno, D. J. Sugarbaker, and M. T. Jaklitsch Effectiveness of Trichostatin A as a Potential Candidate for Anticancer Therapy in Non-Small-Cell Lung Cancer Ann. Thorac. Surg., March 1, 2006; 81(3): 1034 - 1042. [Abstract] [Full Text] [PDF]

				W. J. Lee and B. T. Zhu Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols Carcinogenesis, February 1, 2006; 27(2): 269 - 277. [Abstract] [Full Text] [PDF]

				A. S. Johnson, N. Maronian, and J. Vieira Activation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression during Epithelial Differentiation J. Virol., November 1, 2005; 79(21): 13769 - 13777. [Abstract] [Full Text] [PDF]

				K.-N. Zhao, W. Gu, N. X. Fang, N. A. Saunders, and I. H. Frazer Gene Codon Composition Determines Differentiation-Dependent Expression of a Viral Capsid Gene in Keratinocytes In Vitro and In Vivo Mol. Cell. Biol., October 1, 2005; 25(19): 8643 - 8655. [Abstract] [Full Text] [PDF]

				W. J. Lee, J.-Y. Shim, and B. T. Zhu Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids Mol. Pharmacol., October 1, 2005; 68(4): 1018 - 1030. [Abstract] [Full Text] [PDF]

				A. Altmann, R. B. Schulz, G. Glensch, H. Eskerski, S. Zitzmann, M. Eisenhut, and U. Haberkorn Effects of Pax8 and TTF-1 Thyroid Transcription Factor Gene Transfer in Hepatoma Cells: Imaging of Functional Protein-Protein Interaction and Iodide Uptake J. Nucl. Med., May 1, 2005; 46(5): 831 - 839. [Abstract] [Full Text] [PDF]

				L. Sanderson, G. W. Taylor, E. O. Aboagye, J. P. Alao, J. R. Latigo, R. C. Coombes, and D. M. Vigushin PLASMA PHARMACOKINETICS AND METABOLISM OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A AFTER INTRAPERITONEAL ADMINISTRATION TO MICE Drug Metab. Dispos., October 1, 2004; 32(10): 1132 - 1138. [Abstract] [Full Text] [PDF]

				Y. L. Chung, A.-J. Wang, and L.-F. Yao Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy Mol. Cancer Ther., March 1, 2004; 3(3): 317 - 325. [Abstract] [Full Text]

				N. Takai, J. C. Desmond, T. Kumagai, D. Gui, J. W. Said, S. Whittaker, I. Miyakawa, and H. P. Koeffler Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells Clin. Cancer Res., February 1, 2004; 10(3): 1141 - 1149. [Abstract] [Full Text] [PDF]

				M. Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C. S. Yang Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines Cancer Res., November 15, 2003; 63(22): 7563 - 7570. [Abstract] [Full Text] [PDF]

				G. Grassi, P. Maccaroni, R. Meyer, H. Kaiser, E. D'Ambrosio, E. Pascale, M. Grassi, A. Kuhn, P. Di Nardo, R. Kandolf, et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87 Carcinogenesis, October 1, 2003; 24(10): 1625 - 1635. [Abstract] [Full Text] [PDF]

				D. Cimini, M. Mattiuzzo, L. Torosantucci, and F. Degrassi Histone Hyperacetylation in Mitosis Prevents Sister Chromatid Separation and Produces Chromosome Segregation Defects Mol. Biol. Cell, September 1, 2003; 14(9): 3821 - 3833. [Abstract] [Full Text] [PDF]

				G. Graziani, L. Tentori, I. Portarena, M. Vergati, and P. Navarra Valproic Acid Increases the Stimulatory Effect of Estrogens on Proliferation of Human Endometrial Adenocarcinoma Cells Endocrinology, July 1, 2003; 144(7): 2822 - 2828. [Abstract] [Full Text] [PDF]

				G. Elaut, G. Torok, M. Vinken, G. Laus, P. Papeleu, D. Tourwe, and V. Rogiers Major Phase I Biotransformation Pathways of Trichostatin A in Rat Hepatocytes and in Rat and Human Liver Microsomes Drug Metab. Dispos., December 1, 2002; 30(12): 1320 - 1328. [Abstract] [Full Text] [PDF]

				A. Patnaik, E. K. Rowinsky, M. A. Villalona, L. A. Hammond, C. D. Britten, L. L. Siu, A. Goetz, S. A. Felton, S. Burton, F. H. Valone, et al. A Phase I Study of Pivaloyloxymethyl Butyrate, a Prodrug of the Differentiating Agent Butyric Acid, in Patients with Advanced Solid Malignancies Clin. Cancer Res., July 1, 2002; 8(7): 2142 - 2148. [Abstract] [Full Text] [PDF]

				X. Yu, Z. S. Guo, M. G. Marcu, L. Neckers, D. M. Nguyen, G. A. Chen, and D. S. Schrump Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228 J Natl Cancer Inst, April 3, 2002; 94(7): 504 - 513. [Abstract] [Full Text] [PDF]

				A. J. Burgess, S. Pavey, R. Warrener, L.-J. K. Hunter, T. J. Piva, E. A. Musgrove, N. Saunders, P. G. Parsons, and B. G. Gabrielli Up-Regulation of p21WAF1/CIP1 by Histone Deacetylase Inhibitors Reduces Their Cytotoxicity Mol. Pharmacol., October 1, 2001; 60(4): 828 - 837. [Abstract] [Full Text] [PDF]

				L. M. Butler, Y. Webb, D. B. Agus, B. Higgins, T. R. Tolentino, M. C. Kutko, M. P. LaQuaglia, M. Drobnjak, C. Cordon-Cardo, H. I. Scher, et al. Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase Clin. Cancer Res., April 1, 2001; 7(4): 962 - 970. [Abstract] [Full Text]

				C. Nervi, U. Borello, F. Fazi, V. Buffa, P. G. Pelicci, and G. Cossu Inhibition of Histone Deacetylase Activity by Trichostatin A Modulates Gene Expression during Mouse Embryogenesis without Apparent Toxicity Cancer Res., February 1, 2001; 61(4): 1247 - 1249. [Abstract] [Full Text]

				T. Maeda, M. Towatari, H. Kosugi, and H. Saito Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells Blood, December 1, 2000; 96(12): 3847 - 3856. [Abstract] [Full Text] [PDF]

				Y. Koyama, M. Adachi, M. Sekiya, M. Takekawa, and K. Imai Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis Blood, August 15, 2000; 96(4): 1490 - 1495. [Abstract] [Full Text] [PDF]

				L. Qiu, A. Burgess, D. P. Fairlie, H. Leonard, P. G. Parsons, and B. G. Gabrielli Histone Deacetylase Inhibitors Trigger a G2 Checkpoint in Normal Cells That Is Defective in Tumor Cells Mol. Biol. Cell, June 1, 2000; 11(6): 2069 - 2083. [Abstract] [Full Text]

				Q. Zhou, Z. K. Melkoumian, A. Lucktong, M. Moniwa, J. R. Davie, and J. S. Strobl Rapid Induction of Histone Hyperacetylation and Cellular Differentiation in Human Breast Tumor Cell Lines following Degradation of Histone Deacetylase-1 J. Biol. Chem., November 3, 2000; 275(45): 35256 - 35263. [Abstract] [Full Text] [PDF]

				S. E. Diamond and A. Gutierrez-Hartmann The Pit-1beta Domain Dictates Active Repression and Alteration of Histone Acetylation of the Proximal Prolactin Promoter J. Biol. Chem., September 29, 2000; 275(40): 30977 - 30986. [Abstract] [Full Text] [PDF]

				H. Brinkmann, A. L. Dahler, C. Popa, M. M. Serewko, P. G. Parsons, B. G. Gabrielli, A. J. Burgess, and N. A. Saunders Histone Hyperacetylation Induced by Histone Deacetylase Inhibitors Is Not Sufficient to Cause Growth Inhibition in Human Dermal Fibroblasts J. Biol. Chem., June 15, 2001; 276(25): 22491 - 22499. [Abstract] [Full Text] [PDF]

				C. J. Phiel, F. Zhang, E. Y. Huang, M. G. Guenther, M. A. Lazar, and P. S. Klein Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen J. Biol. Chem., September 21, 2001; 276(39): 36734 - 36741. [Abstract] [Full Text] [PDF]

				A. Derjuga, C. Richard, M. Crosato, P. S. Wright, L. Chalifour, J. Valdez, A. Barraso, H. A. Crissman, W. Nishioka, E. M. Bradbury, et al. Expression of p21Waf1/Cip1 and Cyclin D1 Is Increased in Butyrate-resistant HeLa Cells J. Biol. Chem., October 5, 2001; 276(41): 37815 - 37820. [Abstract] [Full Text] [PDF]

				E. Hu, Z. Chen, T. Fredrickson, Y. Zhu, R. Kirkpatrick, G.-F. Zhang, K. Johanson, C.-M. Sung, R. Liu, and J. Winkler Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor J. Biol. Chem., May 12, 2000; 275(20): 15254 - 15264. [Abstract] [Full Text] [PDF]